HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nunley, D. L. Articles by Starr, A. Search for Related Content PubMed PubMed Citation Articles by Nunley, D. L. Articles by Starr, A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 85, 705-711, Copyright © 1983 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Aortic valve replacement with coronary bypass grafting. Significant determinants of ten-year survival

DL Nunley, GL Grunkemeier and A Starr

Concomitant aortic valve replacement (AVR) and myocardial revascularization were performed on 197 patients between 1969 and 1981. Operative mortality during the period 1969 to 1975 was 15.6% compared to 5.0% for the years 1976 to 1981 (p less than 0.02). The incidence of perioperative myocardial infarction (PMI) declined over the same period from 14.2% to 2.0% (p less than .01). Functional class and left ventricular end-diastolic pressure significantly influenced mortality, whereas age, sex, duration of symptoms, cardiac index, wall motion abnormality, type of valve lesion, and completeness of revascularization did not. Type of myocardial preservation did not significantly affect operative mortality, although a trend favoring either cardioplegia or continuous perfusion of both coronary ostia and grafts was observed. Life-table analysis shows a survival rate during the 10 year follow-up period equal to that of patients undergoing isolated AVR. Cornary bypass grafting (CABG) returns patients with combined aortic valve (AVD) and coronary artery disease (CAD) to a prognostic curve determined by their valvular disease alone.

This article has been cited by other articles:

				2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]

				R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]

				R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]

				J. M. Jones, D. Lovell, G. W. Cran, and S. W. MacGowan Impact of coronary artery bypass grafting on survival after aortic valve replacement Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 327 - 330. [Abstract] [Full Text] [PDF]

				J. P.A. Puvimanasinghe, J. J.M. Takkenberg, M. J.C. Eijkemans, E. W. Steyerberg, L. A. van Herwerden, G. L. Grunkemeier, J. D. F. Habbema, and A. J.J.C. Bogers Choice of a mechanical valve or a bioprosthesis for AVR: does CABG matter? Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 688 - 695. [Abstract] [Full Text] [PDF]

				S. Gall Jr, J. E. Lowe, W. G. Wolfe, H. N. Oldham Jr, P. Van Trigt III, and D. D. Glower Efficacy of the internal mammary artery in combined aortic valve replacement-coronary artery bypass grafting Ann. Thorac. Surg., February 1, 2000; 69(2): 524 - 530. [Abstract] [Full Text] [PDF]

				J. W. Borowiec, T. W. Dubiel, H.-E. Hansson, J. Landelius, S.-O. Nystrom, and J. W. Borowiec Pericarbon Pericardial Valve Prosthesis: Midterm Results of the Aortic Valve Replacement Angiology, January 1, 1998; 49(1): 1 - 11. [Abstract] [PDF]